Publications

PGS Publication/Study ID (PGP) PGS Developed PGS Evaluated First Author Title Journal Name Publication Date Digital object identifier (doi) PubMed ID (PMID)
PGP000228 1 1 Revez JA Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun 02/04/2020 10.1038/s41467-020-15421-7 32242144
PGP000027 1 2 Abraham G Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke. Nat Commun 20/12/2019 10.1038/s41467-019-13848-1 31862893
PGP000046 3 3 Kuchenbaecker K The transferability of lipid loci across African, Asian and European cohorts. Nat Commun 24/09/2019 10.1038/s41467-019-12026-7 31551420
PGP000206 1 1 Teumer A Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. Nat Commun 11/09/2019 10.1038/s41467-019-11576-0 31511532
PGP000625 0 1 Lakeman IMM Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort. Genet Med 06/07/2020 10.1038/s41436-020-0884-4 32624571
PGP000117 2 5 Barnes DR Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genet Med 15/07/2020 10.1038/s41436-020-0862-x 32665703
PGP000277 2 2 Dareng EO Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet 14/01/2022 10.1038/s41431-021-00987-7 35027648
PGP000310 1 1 Canzian F A polygenic risk score for multiple myeloma risk prediction. Eur J Hum Genet 30/11/2021 10.1038/s41431-021-00986-8 34845334
PGP000194 1 1 Barnes CLK Contribution of common risk variants to multiple sclerosis in Orkney and Shetland. Eur J Hum Genet 04/06/2021 10.1038/s41431-021-00914-w 34088990
PGP000165 2 2 Cherny SS Self-reported hearing loss questions provide a good measure for genetic studies: a polygenic risk score analysis from UK Biobank. Eur J Hum Genet 20/03/2020 10.1038/s41431-020-0603-2 32203203
PGP000097 3 3 Flynn E Sex-specific genetic effects across biomarkers. Eur J Hum Genet 01/09/2020 10.1038/s41431-020-00712-w 32873964
PGP000515 1 1 Tamlander M Genome-wide polygenic risk scores for colorectal cancer have implications for risk-based screening Br J Cancer 13/11/2023 10.1038/s41416-023-02536-z 38172535
PGP000367 0 1 Green HD Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank. Br J Cancer 18/08/2022 10.1038/s41416-022-01918-z 35978138
PGP000300 1 1 Zhang P Association of smoking and polygenic risk with the incidence of lung cancer: a prospective cohort study. Br J Cancer 22/02/2022 10.1038/s41416-022-01736-3 35194190
PGP000072 1 1 Smith T The added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort study. Br J Cancer 16/10/2018 10.1038/s41416-018-0282-8 30323197
PGP000370 6 6 Gui Y Sex-specific genetic association between psychiatric disorders and cognition, behavior and brain imaging in children and adults. Transl Psychiatry 26/08/2022 10.1038/s41398-022-02041-6 36028495
PGP000346 1 1 Lai D Gene-based polygenic risk scores analysis of alcohol use disorder in African Americans. Transl Psychiatry 05/07/2022 10.1038/s41398-022-02029-2 35790736
PGP000084 6 6 Barr PB Using polygenic scores for identifying individuals at increased risk of substance use disorders in clinical and population samples. Transl Psychiatry 18/06/2020 10.1038/s41398-020-00865-8 32555147
PGP000174 1 1 Guffanti G Depression genetic risk score is associated with anhedonia-related markers across units of analysis. Transl Psychiatry 19/09/2019 10.1038/s41398-019-0566-7 31537779
PGP000397 1 1 Huynh-Le MP Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. Prostate Cancer Prostatic Dis 12/02/2022 10.1038/s41391-022-00497-7 35152271
PGP000219 0 1 Huynh-Le MP Common genetic and clinical risk factors: association with fatal prostate cancer in the Cohort of Swedish Men. Prostate Cancer Prostatic Dis 15/03/2021 10.1038/s41391-021-00341-4 33723363
PGP000150 1 2 Karunamuni RA Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer. Prostate Cancer Prostatic Dis 08/01/2021 10.1038/s41391-020-00311-2 33420416
PGP000521 1 1 Merino J Genetic predisposition to macronutrient preference and workplace food choices. Mol Psychiatry 23/05/2023 10.1038/s41380-023-02107-x 37217678
PGP000569 1 1 Lake J Multi-ancestry meta-analysis and fine-mapping in Alzheimer's disease. Mol Psychiatry 18/05/2023 10.1038/s41380-023-02089-w 37198259
PGS000080 1 1 Coleman JRI Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank. Mol Psychiatry 23/01/2020 10.1038/s41380-019-0546-6 31969693
PGP000448 8 8 Berndt SI Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia 22/10/2022 10.1038/s41375-022-01711-0 36273105
PGP000234 0 1 Kleinstern G Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans. Leukemia 20/07/2021 10.1038/s41375-021-01344-9 34285341
PGP000677 0 4 Renier TJ Elucidating pathways to pediatric obesity: a study evaluating obesity polygenic risk scores related to appetitive traits in children. Int J Obes (Lond) 22/09/2023 10.1038/s41366-023-01385-3 37736781
PGP000195 1 0 Ferreira MA Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat Genet 30/10/2017 10.1038/ng.3985 29083406
PGP000223 1 1 Lotta LA Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet 14/11/2016 10.1038/ng.3714 27841877
PGP000010 1 1 Läll K Personalized risk prediction for type 2 diabetes: the potential of genetic risk scores. Genet Med 11/08/2016 10.1038/gim.2016.103 27513194
PGP000032 0 1 Pashayan N Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. Genet Med 08/01/2015 10.1038/gim.2014.192 25569441
PGP000031 1 1 Pashayan N Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. Br J Cancer 20/08/2015 10.1038/bjc.2015.289 26291059
PGP000264 2 2 Moll M Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts. Lancet Respir Med 01/07/2020 10.1016/s2213-2600(20)30101-6 32649918
PGP000049 1 1 Dai J Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir Med 17/07/2019 10.1016/S2213-2600(19)30144-4 31326317
PGP000025 1 1 Belsky DW Polygenic risk and the development and course of asthma: an analysis of data from a four-decade longitudinal study. Lancet Respir Med 28/06/2013 10.1016/S2213-2600(13)70101-2 24429243
PGP000235 2 2 Nalls MA Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol 01/12/2019 10.1016/s1474-4422(19)30320-5 31701892
PGP000207 1 1 van der Lee SJ The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study. Lancet Neurol 16/03/2018 10.1016/s1474-4422(18)30053-x 29555425
PGP000387 1 2 Qin N Association of the interaction between mosaic chromosomal alterations and polygenic risk score with the risk of lung cancer: an array-based case-control association and prospective cohort study. Lancet Oncol 17/10/2022 10.1016/s1470-2045(22)00600-3 36265503
PGP000292 0 3 Saad M Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study. Lancet Oncol 09/02/2022 10.1016/s1470-2045(21)00752-x 35150601
PGP000003 1 1 Mega JL Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet 04/03/2015 10.1016/S0140-6736(14)61730-X 25748612
PGP000200 1 1 Talmud PJ Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet 22/02/2013 10.1016/s0140-6736(12)62127-8 23433573
PGP000191 1 1 He CY Performance of common genetic variants in risk prediction for colorectal cancer in Chinese: A two-stage and multicenter study. Genomics 02/02/2021 10.1016/j.ygeno.2021.01.025 33545268
PGP000679 130 130 Gunn S Comparison of Methods for Building Polygenic Scores for Diverse Populations. HGG Adv 25/09/2024 10.1016/j.xhgg.2024.100355 39323095
PGP000193 5 5 Polfus LM Genetic discovery and risk characterization in type 2 diabetes across diverse populations. HGG Adv 09/03/2021 10.1016/j.xhgg.2021.100029 34604815
PGP000604 158 158 Truong B Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases. Cell Genom 12/03/2024 10.1016/j.xgen.2024.100523 38508198
PGP000463 2 2 Kleeman SO Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy. Cell Genom 23/06/2023 10.1016/j.xgen.2023.100347 37601967
PGP000592 1 1 Wu Y 150 risk variants for diverticular disease of intestine prioritize cell types and enable polygenic prediction of disease susceptibility. Cell Genom 05/06/2023 10.1016/j.xgen.2023.100326 37492107
PGP000262 18 18 Wang Y Global Biobank analyses provide lessons for developing polygenic risk scores across diverse cohorts. Cell Genom 04/01/2023 10.1016/j.xgen.2022.100241 36777179
PGP000271 5 5 Mars N Genome-wide risk prediction of common diseases across ancestries in one million people. Cell Genom 13/04/2022 10.1016/j.xgen.2022.100118 35591975